Pricing Log in Create free account

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) vs TherapeuticsMD, Inc. (TXMD)

Shuttle Pharmaceuticals Holdings, Inc. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Shuttle Pharmaceuticals Holdings, Inc. is the larger, with a market value of $24.0M against $19.8M — 1.2× the size. Shuttle Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −6.64%) and the lower return on invested capital (−36.7% vs −13.8%). Across the 13 metrics below, TherapeuticsMD, Inc. leads on 8 and Shuttle Pharmaceuticals Holdings, Inc. on 5.

Valuation

Metric SHPH TXMD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 6.12 2.08
P/B 0.27 0.74 1.79
Price to free cash flow n/m 7.36 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 84.46 2.87
Earnings yield (533.70%) (1.35%) (15.94%)
Free cash flow yield (128.57%) 13.59% 0.00%

Profitability

Metric SHPH TXMD Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 100.00% 53.51%
Operating margin 0.00% (120.89%) 0.00%
Net margin 0.00% (6.64%) (2.45%)
Free cash flow margin 0.00% 94.71% 0.00%
Return on equity (90.05%) (0.80%) (0.80%)
Return on assets (72.47%) (0.57%) (1.67%)
Return on invested capital (36.73%) (13.77%) 0.00%

Growth

Metric SHPH TXMD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 27.78% 5.22%
EPS growth (last fiscal year) 91.32% 73.68% 42.91%
Revenue growth, 5-year CAGR — (45.84%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SHPH TXMD Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 0.11 3.22 2.41
Net debt to EBITDA 0.03 2.34 1.01

Dividend

Metric SHPH TXMD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric SHPH TXMD Drug Manufacturers Specialty & Generic median
Market cap 24.01m 19.80m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack